| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
565,813,000 |
| Market
Cap: |
13.62(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.1 - $24.91 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 13.1 |
| Insider 6 Months : 13.1 |
| Insider 3/6 Months : 25.9 |
|
| Guru Rank Number : 968 |
| Guru Rank Value : 0.7 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Elanco Animal Health is an animal health company. Co. groups its products into four principal categories: Companion Animal (CA) Disease Prevention, which includes parasiticides and vaccine products for canines and felines; CA Therapeutics, which includes products for the treatment of pain, osteoarthritis, otitis, cardiovascular and dermatology indications in canines and felines; Food Animal (FA) Future Protein and Health, which includes vaccines, antibiotics, parasiticides and other products used in poultry and aquaculture production; and FA Ruminants and Swine, which includes vaccines, antibiotics, implants, parasiticides and other products used in ruminants and swine production.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
43,450 |
43,450 |
88,450 |
245,050 |
| Total Buy Value |
$937,907 |
$937,907 |
$1,421,465 |
$3,646,551 |
| Total People Bought |
4 |
4 |
5 |
7 |
| Total Buy Transactions |
4 |
4 |
7 |
13 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-11-02 |
2025-08-01 |
2025-01-31 |
2024-02-01 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hoover R David |
|
– • – |
2025-12-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
60,000 |
150,000 |
|
- |
|
| Kurzius Lawrence Erik |
|
– • – |
2025-12-12 |
4 |
B |
$21.30 |
$213,000 |
D/D |
10,000 |
131,773 |
0.01 |
14% |
|
| Vanhimbergen Robert M |
EVP and CFO |
• – – |
2025-12-11 |
4 |
B |
$21.64 |
$150,426 |
D/D |
6,950 |
124,233 |
0.01 |
14% |
|
| Simmons Jeffrey N |
PRESIDENT, CEO AND DIRECTOR |
• • – |
2025-12-11 |
4 |
B |
$21.75 |
$478,496 |
I/I |
22,000 |
167,000 |
0.01 |
14% |
|
| Modi Rajeev A. |
SEE REMARKS |
• – – |
2025-12-11 |
4 |
B |
$21.33 |
$95,985 |
D/D |
4,500 |
123,082 |
0.01 |
14% |
|
| Ma Stacey |
|
– • – |
2025-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,314 |
12,853 |
|
- |
|
| Garcia Art A |
|
– • – |
2025-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,314 |
91,278 |
|
- |
|
| Harrington Michael J |
|
– • – |
2025-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,314 |
109,577 |
|
- |
|
| Kochevar Deborah Turner |
|
– • – |
2025-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,314 |
89,714 |
|
- |
|
| Kurzius Lawrence Erik |
|
– • – |
2025-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,314 |
121,773 |
|
- |
|
| Hoover R David |
|
– • – |
2025-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,314 |
106,773 |
|
- |
|
| Mcdonald Kirk P |
|
– • – |
2025-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,314 |
88,714 |
|
- |
|
| Anand Kapila K |
|
– • – |
2025-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,314 |
94,973 |
|
- |
|
| Herendeen Paul |
|
– • – |
2025-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,314 |
84,813 |
|
- |
|
| Pollard-Knight Denise |
|
– • – |
2025-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,314 |
88,714 |
|
- |
|
| Vanhimbergen Robert M |
EVP and CFO |
• – – |
2025-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
109,857 |
109,857 |
|
- |
|
| Vanhimbergen Robert M |
EVP and CFO |
• – – |
2025-07-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,426 |
|
58% |
|
| Mcardle Grace |
EVP, MANUFACTURING AND QUALITY |
• – – |
2025-07-03 |
4 |
D |
$14.64 |
$63,625 |
D/D |
(4,346) |
76,049 |
|
- |
|
| Meer James M |
CHIEF ACCOUNTING OFFICER |
• – – |
2025-07-03 |
4 |
D |
$14.64 |
$16,997 |
D/D |
(1,161) |
58,103 |
|
- |
|
| Bettington Timothy J |
SEE REMARKS |
• – – |
2025-04-03 |
4 |
D |
$9.72 |
$228,984 |
D/D |
(23,558) |
110,262 |
|
- |
|
| Kurzius Lawrence Erik |
|
– • – |
2025-03-11 |
4 |
B |
$10.20 |
$102,000 |
D/D |
10,000 |
111,459 |
0.01 |
46% |
|
| Kurzius Lawrence Erik |
|
– • – |
2025-03-07 |
4 |
B |
$10.90 |
$109,000 |
D/D |
10,000 |
101,459 |
0.01 |
34% |
|
| Hoover R David |
|
– • – |
2025-03-05 |
4 |
B |
$10.90 |
$272,558 |
I/I |
25,000 |
210,000 |
0.01 |
35% |
|
| Young Todd S. |
SEE REMARKS |
• – – |
2025-03-04 |
4 |
GA |
$0.00 |
$0 |
I/I |
8,000 |
5,500 |
|
- |
|
| Young Todd S. |
SEE REMARKS |
• – – |
2025-03-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,000 |
149,308 |
|
- |
|
479 Records found
|
|
Page 1 of 20 |
|
|
0.12 (0.5%) 
